PATENT CLAIM ANALYSIS

Application Number: 16007095
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "489000"]

Abstract:
Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

Claim (Index 25):
The method of  claim 1 , wherein the lung disorder comprises a lung tumor, and wherein the treating comprises elimination of the tumor.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15895197', '15174505', '13779625', '12436697', '15460552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6989996318437249
- 35 USC 102 Novelty (BERT): 0.5212325128862599
- Combined Prediction Score: 0.6812229199479785
- Mean Citation Score: 270.84776600000004
- Max Citation Score: 316.4046600000001
- Similarity Product: 227.73649327857265

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test